PARP-14 combines with tristetraprolin in the selective posttranscriptional control of macrophage tissue factor

M Bilal Iqbal1, Michael Johns1, Jun Cao1

  • 1Vascular Sciences Section, National Heart and Lung Institute, Imperial College London, United Kingdom;

Blood
|October 9, 2014
PubMed

Insights

Poly(ADP-ribose)-polymerase (PARP)-14 selectively regulates tissue factor (TF) mRNA stability in macrophages. PARP-14 deficiency increases TF expression and activity by stabilizing TF mRNA, impacting thrombosis and inflammation.

Area of Science:

  • Molecular Biology
  • Immunology
  • Hematology

Background:

  • Tissue factor (TF) is a key initiator of the extrinsic coagulation cascade, linking thrombosis and inflammation.
  • Macrophage TF expression is regulated post-transcriptionally, but the underlying mechanisms remain largely unknown.
  • Poly(ADP-ribose)-polymerase (PARP)-14 is an intracellular protein involved in ADP-ribose posttranslational modifications.

Purpose of the Study:

  • To investigate the role of PARP-14 in the posttranscriptional regulation of macrophage TF expression.
  • To elucidate the molecular mechanism by which PARP-14 controls TF mRNA stability.

Main Methods:

  • Utilized PARP-14-deficient macrophages and mice models.
  • Employed ribonucleoprotein complex immunoprecipitation and biotinylated RNA pull-down assays.
  • Analyzed TF and tumor necrosis factor-alpha (TNFα) mRNA stability and expression levels.

Main Results:

  • PARP-14 deficiency in macrophages resulted in increased TF expression and activity following lipopolysaccharide challenge.
  • This increase was attributed to enhanced TF mRNA stability, mediated by PARP-14's interaction with tristetraprolin (TTP) and the TF mRNA 3' UTR.
  • TF mRNA regulation by PARP-14 was selective, as TNFα mRNA stability and expression remained unaffected.

Conclusions:

  • PARP-14 plays a crucial role in the selective posttranscriptional regulation of TF expression in macrophages.
  • PARP-14 stabilizes TF mRNA by interacting with TTP, providing a novel regulatory mechanism.
  • This finding offers new insights into the control of coagulation and inflammation at the posttranscriptional level.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K